CIK: 0001637359 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 20, 2019
Total Value ($000): $311,888
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio | 6,953,416 | $150,681 | 48.3% | $20.85 | 0.0% | — | 38341P102 |
| REPL | Replimune | 5,103,455 | $77,425 | 24.8% | $17.53 | -28.9% | — | 76029N106 |
| — | Translate Bio | 2,437,603 | $24,839 | 8.0% | $12.65 | — | — | 89374L104 |
| — | Paratek Pharmaceuticals | 2,600,410 | $13,938 | 4.5% | $34.18 | — | — | 699374302 |
| — | ObsEva | 999,364 | $12,782 | 4.1% | $9.76 | — | — | H5861P103 |
| — | CymaBay Therapeutics | 551,477 | $7,324 | 2.3% | $4.71 | — | — | 23257D103 |
| — | FibroGen | 130,646 | $7,101 | 2.3% | $27.34 | — | — | 31572Q808 |
| — | Cidara Therapeutics | 1,508,794 | $3,998 | 1.3% | $6.73 | — | — | 171757107 |
| — | ESSA Pharma | 1,084,848 | $3,698 | 1.2% | $3.00 | — | — | 29668H708 |
| — | Jounce Therapeutics | 529,965 | $3,286 | 1.1% | $21.99 | — | — | 481116101 |
| — | Pieris Pharmaceuticals | 778,230 | $2,607 | 0.8% | $1.83 | — | — | 720795103 |
| — | Dicerna Pharmaceuticals | 167,157 | $2,449 | 0.8% | $16.47 | — | — | 253031108 |
| SNNAQ | Sienna Biopharmaceuticals | 758,610 | $1,760 | 0.6% | $21.95 | -87.7% | — | 82622H108 |